149. Hemiconvulsion hemiplegia epilepsy syndrome Clinical trials / Disease details
Clinical trials : 25 / Drugs : 40 - (DrugBank : 14) / Drug target genes : 17 - Drug target pathways : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04020848 (ClinicalTrials.gov) | October 28, 2019 | 12/7/2019 | Observe Alternating Hemiplegia of Childhood (OBSERV-AHC) Study | Observe Alternating Hemiplegia of Childhood (OBSERV-AHC) Prospective Observational Natural History and Therapy Study | Alternating Hemiplegia | Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.;Other: The patients' parents have to complete the VINELAND II adaptive behavior scales scoring, The Sleep Disturbance Scale for Children (SDSC) and Horne & Ostberg Circadian Typology Questionnaire | Hospices Civils de Lyon | NULL | Recruiting | N/A | N/A | All | 40 | France |